Wang Chenhao, Li Wenfan, Yang Peng, Lu Chen, Zhang Yu, Wang Haiyue, Xiao Zhenghua, Hu Jia
Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan Province, P.R. China.
Department of Cardiothoracic Surgery, West China Guang'an Hospital, Sichuan University, Guang'an, Sichuan Province, P.R. China.
Interdiscip Cardiovasc Thorac Surg. 2024 Mar 29;38(4). doi: 10.1093/icvts/ivae049.
The primary objective of this research was to evaluate the safety and feasibility of an innovative double-branched stent graft system employing four-stage deployment technology for aortic arch repair in porcine models.
The double-branched stent graft system consisted of a proximal polyester artificial blood vessel, the main and double-branched stent grafts and a delivery system. We utilized 12 healthy pigs as experimental animals (6 per group). Postimplantation, samples were collected at 90 and 180 days after the operations. Preoperative and postoperative imaging and intraoperative arterial blood gas analyses were performed. After the pigs were euthanized, the implanted product, surrounding tissue and major organs were collected for pathological analysis.
The technical success rate of the stent graft implants was 100% (12/12). All animals survived to the experimental end point. Perioperative assessments showed intact stent grafts, and imaging features at the end of the follow-up period revealed neither endoleak nor device migration. No major adverse cardiovascular events were observed during the postoperative follow-up period. Pathological examinations confirmed the satisfactory biocompatibility of the stent graft.
This innovative double-branched stent graft system with four-stage deployment technology was affirmed as a safe and feasible option for aortic arch repair in accordance with our preclinical evaluation with porcine models.
本研究的主要目的是评估一种采用四阶段展开技术的创新型双分支支架移植物系统在猪模型中进行主动脉弓修复的安全性和可行性。
双分支支架移植物系统由近端聚酯人造血管、主支架移植物和双分支支架移植物以及输送系统组成。我们使用12只健康猪作为实验动物(每组6只)。植入后,在术后90天和180天采集样本。进行术前和术后成像以及术中动脉血气分析。在猪安乐死后,收集植入产品、周围组织和主要器官进行病理分析。
支架移植物植入的技术成功率为100%(12/12)。所有动物均存活至实验终点。围手术期评估显示支架移植物完好,随访期末的成像特征显示无内漏和器械移位。术后随访期间未观察到重大不良心血管事件。病理检查证实支架移植物具有令人满意的生物相容性。
根据我们在猪模型中的临床前评估,这种采用四阶段展开技术的创新型双分支支架移植物系统被确认为主动脉弓修复的一种安全可行的选择。